Four IPOs priced this past week, led by three sizable biotechs. They were joined by 11 blank check listings. Coagulation disorder biotech Hemab Therapeutics (COAG) upsized and priced at the high end to raise $302 million at an $849 million market cap. Hemab...read more
Pershing Square USA, a closed-end investment vehicle formed by Bill Ackman, raised $5 billion by selling shares at $50 per share. The company raised $2.2 billion by selling 44 million shares in a registered offering to public investors, as well as $2.8 billion...read more
Updated Monday, 4/27. A handful of IPOs are currently scheduled for the week ahead, joined by Bill Ackman’s Pershing Square deals. Some smaller issuers may also join the calendar throughout the week. Neuropsychiatric therapeutics biotech ...read more
There’s not much on the IPO calendar in the week ahead, though a closed-end fund is slated to complete a billion-dollar offering. While not included in our stats, Bill Ackman’s Pershing Square USA (PSUS) is expected to raise up to $4 billion and...read more
US IPO Weekly Recap: Biotech, early-stage mining, and Bill Ackman close out the April IPO market
Four IPOs priced this past week, led by three sizable biotechs. They were joined by 11 blank check listings. Coagulation disorder biotech Hemab Therapeutics (COAG) upsized and priced at the high end to raise $302 million at an $849 million market cap. Hemab...read more
Bill Ackman's closed-end fund Pershing Square USA prices $5 billion IPO at $50 per share; manager Pershing Square Inc. also set to trade on the NYSE
Pershing Square USA, a closed-end investment vehicle formed by Bill Ackman, raised $5 billion by selling shares at $50 per share. The company raised $2.2 billion by selling 44 million shares in a registered offering to public investors, as well as $2.8 billion...read more
US IPO Week Ahead: Biotechs, mining, and Bill Ackman deals set to debut
Updated Monday, 4/27. A handful of IPOs are currently scheduled for the week ahead, joined by Bill Ackman’s Pershing Square deals. Some smaller issuers may also join the calendar throughout the week. Neuropsychiatric therapeutics biotech ...read more
US IPO Week Ahead: July IPO market set to end with a quiet week
There’s not much on the IPO calendar in the week ahead, though a closed-end fund is slated to complete a billion-dollar offering. While not included in our stats, Bill Ackman’s Pershing Square USA (PSUS) is expected to raise up to $4 billion and...read more